Here are a few of the most interesting Reata Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Reata Pharmaceuticals Facts
- Website: Official Website
- Year Founded: 2002
- Headquarters: Irving, TX
- Founder(s): J Warren Huff
What is Reata Pharmaceuticals?
Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. (source)
Reata Pharmaceuticals Employee Count
Number of Reata Pharmaceuticals employees:
Last updated 1/1/20
Reata Pharmaceuticals Revenue Totals
Reata Pharmaceuticals annual revenue:
- 2019: $26 million
- 2018: $53 million
- 2017: $48 million
- 2016: $49 million
- 2015: $50 million
Reata Pharmaceuticals annual net income:
- 2019: $290 million net loss
- 2018: $80 million net loss
- 2017: $47 million net loss
- 2016: $6 million net loss
- 2015: $1 million net loss